» Articles » PMID: 26413483

Metabolic Bone Disease in the Preterm Infant: Current State and Future Directions

Overview
Specialty General Medicine
Date 2015 Sep 29
PMID 26413483
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Neonatal osteopenia is an important area of interest for neonatologists due to continuing increased survival of preterm infants. It can occur in high-risk infants such as preterm infants, infants on long-term diuretics or corticosteroids, and those with neuromuscular disorders. Complications such as rickets, pathological fractures, impaired respiratory function and poor growth in childhood can develop and may be the first clinical evidence of the condition. It is important for neonatologists managing such high-risk patients to regularly monitor biochemical markers for evidence of abnormal bone turnover and inadequate mineral intake in order to detect the early phases of impaired bone mineralization. Dual-energy X-ray absorptiometry has become an increasingly used research tool for assessing bone mineral density in children and neonates, but more studies are still needed before it can be used as a useful clinical tool. Prevention and early detection of osteopenia are key to the successful management of this condition and oral phosphate supplements should be started as soon as is feasible.

Citing Articles

Effects of vitamin D supplementation on serum 25(OH)D levels and neurobehavioral development in premature infants after birth.

Guo H, Xie J, Yu X, Tian Y, Guan M, Wei J Sci Rep. 2024; 14(1):23972.

PMID: 39397102 PMC: 11471846. DOI: 10.1038/s41598-024-75191-w.


Diagnostics of Metabolic Bone Disease in Extremely Preterm Infants-Clinical Applicability of Bone Turnover Biochemical Markers and Quantitative Ultrasound.

Cerar S, Vurzer L, Salamon A, Kornhauser Cerar L, Trdan M, Robek D Children (Basel). 2024; 11(7).

PMID: 39062233 PMC: 11275004. DOI: 10.3390/children11070784.


Nutritional management after necrotizing enterocolitis and focal intestinal perforation in preterm infants.

Mo I, Lapillonne A, van den Akker C, Khashu M, Johnson M, McElroy S Pediatr Res. 2024; .

PMID: 38992154 DOI: 10.1038/s41390-024-03386-y.


Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity.

Llorente-Pelayo S, Docio P, Arriola S, Lavin-Gomez B, Garcia-Unzueta M, Ballesteros M BMC Pediatr. 2024; 24(1):418.

PMID: 38951759 PMC: 11218264. DOI: 10.1186/s12887-024-04897-7.


Metabolic bone disease of prematurity screening and individualized enteral mineral supplementation in high-risk neonates: a quality improvement initiative.

Creed P, Huff K, Beard K, DiMeglio L, Stefanescu B J Perinatol. 2024; 44(9):1369-1376.

PMID: 38321167 DOI: 10.1038/s41372-024-01892-9.


References
1.
Backstrom M, Kouri T, Kuusela A, Sievanen H, Koivisto A, Ikonen R . Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000; 89(7):867-73. View

2.
Moyer-Mileur L, Brunstetter V, McNaught T, Gill G, Chan G . Daily physical activity program increases bone mineralization and growth in preterm very low birth weight infants. Pediatrics. 2000; 106(5):1088-92. DOI: 10.1542/peds.106.5.1088. View

3.
Goulding A, Jones I, Taylor R, Williams S, Manning P . Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr. 2001; 139(4):509-15. DOI: 10.1067/mpd.2001.116297. View

4.
Zamora S, Belli D, Rizzoli R, Slosman D, Bonjour J . Lower femoral neck bone mineral density in prepubertal former preterm girls. Bone. 2001; 29(5):424-7. DOI: 10.1016/s8756-3282(01)00596-8. View

5.
Nemet D, Dolfin T, Wolach B, Eliakim A . Quantitative ultrasound measurements of bone speed of sound in premature infants. Eur J Pediatr. 2002; 160(12):736-40. DOI: 10.1007/s004310100849. View